Asim Shabbir Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Researcher

Last publication 2025 Last refreshed 2026-04-18

faculty

44 h-index 378 pubs 7,736 cited

Biography and Research Information

OverviewAI-generated summary

Asim Shabbir's research program focuses on gastrointestinal diseases, surgical outcomes, and metabolic health. He has published work investigating single-cell atlases of lineage states in gastric cancer, the role of hedgehog signaling in mediating PD-L1 expression in gastric cancer organoids, and risk prediction models for mortality after esophagectomy for cancer. His work also extends to metabolic health, with publications on cardiovascular-liver-metabolic health recommendations for managing metabolic dysfunction-associated steatotic liver disease and the regulation of adipogenic differentiation by interferon regulatory factor 3.

Shabbir's contributions also include studies on bariatric surgery, with publications on patient selection for one anastomosis/mini gastric bypass and consensus statements on sleeve gastrectomy. He has also examined outcomes after minimally invasive versus hybrid and open esophagectomy. With a h-index of 45 and over 7,700 citations across 382 publications, his work is recognized as highly impactful and highly cited.

Metrics

  • h-index: 44
  • Publications: 378
  • Citations: 7,736

Selected Publications

  • Ceramide-induced FGF13 impairs systemic metabolic health (2025)
    4 citations DOI OpenAlex
  • International expert consensus on the current status and future prospects of artificial intelligence in metabolic and bariatric surgery (2025)
    7 citations DOI OpenAlex
  • Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach (2024)
    82 citations DOI OpenAlex
  • Serum lipidomic signatures in patients with varying histological severity of metabolic-dysfunction associated steatotic liver disease (2024)
    11 citations DOI OpenAlex
  • Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden (2024)
    4 citations DOI OpenAlex
  • Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes (2024)
    13 citations DOI OpenAlex
  • Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases (2024)
    39 citations DOI OpenAlex
  • Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals (2024)
    19 citations DOI OpenAlex
  • Metabolic and Bariatric Surgeon Criteria—An International Experts’ Consensus (2024)
    6 citations DOI OpenAlex
  • Revision/Conversion Surgeries After One Anastomosis Gastric Bypass—An Experts’ Modified Delphi Consensus (2024)
    14 citations DOI OpenAlex
  • Sex differences in optimal medical therapy following invasive angiography for coronary artery disease (2024)
    2 citations DOI OpenAlex
  • Technical Variations and Considerations around OAGB in IFSO-APC and IFSO-MENAC Chapters, an Expert Survey (2024)
    10 citations DOI OpenAlex
  • Effectiveness of an Artificial Intelligence-Assisted App for Improving Eating Behaviors: Mixed Methods Evaluation (2024)
    28 citations DOI OpenAlex
  • The feasibility and outcomes of metabolic and bariatric surgery prior to neoplastic therapy (2024)
    14 citations DOI OpenAlex
  • The Management of Biliary Disease in Patients with Severe Obesity Undergoing Metabolic and Bariatric Surgery—An International Expert Survey (2024)
    9 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

524 Collaborators 215 Institutions 46 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics